News from medicines patent pool A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

12 Nov, 2018, 17:30 GMT The Medicines Patent Pool Signs Licence with AbbVie to Expand Access to Key Hepatitis C Treatment, Glecaprevir/Pibrentasvir

Important collaboration will ensure affordable hepatitis C treatment options in low- and middle-income countries. The Medicines Patent Pool (MPP) has ...


12 Nov, 2018, 17:30 GMT The Medicines Patent Pool Signs Licence With AbbVie to Expand Access to Key Hepatitis C Treatment, glecaprevir/pibrentasvir

The Medicines Patent Pool (MPP) has announced a new, royalty-free licence agreement with AbbVie for glecaprevir/pibrentasvir (G/P) - a World Health...


12 Nov, 2018, 14:00 GMT The Medicines Patent Pool Signs Licence With AbbVie to Expand Access to Key Hepatitis C Treatment, glecaprevir/pibrentasvir

The Medicines Patent Pool (MPP) has announced a new, royalty-free licence agreement with AbbVie for glecaprevir/pibrentasvir (G/P) - a World Health...


24 May, 2018, 18:00 BST The Medicines Patent Pool Presents New Five-Year Strategy for Improving Access to Priority Treatments in Developing Countries

Strategy and Related Feasibility Study Call for the Expansion of the MPP's Mandate to Patented Medicines on the World Health Organization's Model...


02 May, 2018, 13:27 BST The Medicines Patent Pool Adds New Suppliers from South Africa and South Korea to its Growing Generic Manufacturing Network

Twenty-five product developers now working with the MPP to manufacture low-cost, quality-assured treatments for developing countries The Medicines...


19 Apr, 2018, 10:58 BST The Medicines Patent Pool Governance Board Appoints Charles Gore as New MPP Executive Director

Former President of the World Hepatitis Alliance brings two decades of experience in public health, patient advocacy and coalition-building to the...


04 Oct, 2017, 08:01 BST The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir

The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for bictegravir (BIC), now under review in the United States and the...


25 Jul, 2017, 18:00 BST Bristol-Myers Squibb, Medicines Patent Pool Extend Licence for Atazanavir to 122 Developing Countries

Extension of 2013 agreement allows an additional 1.4 million people living with HIV to benefit from sublicensed generics of World Health...


03 Jul, 2017, 10:00 BST The Medicines Patent Pool Governance Board Appoints Marie-Paule Kieny as New Chair

The Medicines Patent Pool (MPP) Governance Board today announced the appointment of Dr. Marie-Paule Kieny as its new chair, effective 1 September...


21 Apr, 2017, 08:00 BST The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir

Agreement seeks to improve health options for hepatitis C patients in low- and middle-income countries The Medicines Patent Pool (MPP) announced a...


24 Mar, 2017, 04:01 GMT TB Alliance Sublicenses Promising Anti-tuberculosis Drug from the Medicines Patent Pool

Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer On World...


25 Jan, 2017, 00:01 GMT The Medicines Patent Pool Announces First Licence for Tuberculosis Treatment

In an effort to improve the international response to combatting multidrug-resistant TB, MPP and Johns Hopkins University sign licensing agreement...


07 Jul, 2016, 09:00 BST The Medicines Patent Pool Signs New Round of Generic Manufacturing Licences for HIV and Hepatitis C Treatments

Zydus Cadila Joins the MPP as New Partner The Medicines Patent Pool (MPP) announced new generic manufacturing licences today for four antiretrovirals ...


25 Apr, 2016, 11:05 BST ViiV Healthcare, Medicines Patent Pool Extend Licence for Dolutegravir to All Lower Middle-Income Countries

Specifically benefits more than 270,000 people living with HIV in Armenia, Moldova, Morocco and Ukraine The Medicines Patent Pool (MPP) and ViiV...


20 Jan, 2016, 09:57 GMT The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

Four companies to help speed access to curative direct-acting antiviral in 112 low- and middle-income countries The Medicines Patent Pool (MPP)...


18 Dec, 2015, 09:00 GMT The Medicines Patent Pool and AbbVie Sign Licensing Agreement to Increase Access to Crucial HIV Treatments Throughout Africa

MPP, AbbVie and South African Department of Health work together to establish long-term solutions for antiretroviral therapies (ARVs) The Medicines...


01 Dec, 2015, 00:01 GMT The Medicines Patent Pool (MPP) Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines

Partnership includes an MPP licence for the university's Solid Drug Nanoparticle (SDN) Technology; Aims to support treatment scale-up through cost...


23 Nov, 2015, 14:51 GMT The Medicines Patent Pool Signs Licence with Bristol-Myers Squibb to Increase Access to Hepatitis C Medicine daclatasvir

The royalty-free agreement allows manufacturers to develop daclatasvir for 112 low- and middle-income countries The Medicines Patent Pool (MPP) today ...


06 Nov, 2015, 11:57 GMT The Medicines Patent Pool Expands Mandate to Hepatitis C and Tuberculosis Treatment

MPP's voluntary licensing work could benefit millions of patients in low- and middle-income countries The Medicines Patent Pool (MPP), the world's...


27 Oct, 2015, 09:00 GMT The Medicines Patent Pool Announces Expansion of its Governance Board

Four new experts in access to medicines, intellectual property and industry will help guide foundation in coming years The Medicines Patent Pool...


01 Jul, 2015, 14:26 BST The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs)

Lupin, Strides, HEC Group, Huahai Bring Total Number of MPP Sub-licensees to Fourteen Companies The Medicines Patent Pool (MPP) announced the rapid...


11 Jun, 2015, 13:31 BST The Medicines Patent Pool and Gilead Sciences Expand Licence to Allow Generic Manufacture of Medicines in South Africa

The Medicines Patent Pool (MPP) announced an expansion of its current licensing agreement with Gilead Sciences for generic manufacture of tenofovir...


20 May, 2015, 11:00 BST The Medicines Patent Pool (MPP) Releases 2014 Annual Report: Highlights Progress in Increasing Access to HIV Medicines

MPP signed 20 licensing agreements last year and is now working with 10 generic manufacturers on more than 50 medicine development projects The...


01 Apr, 2014, 19:30 BST Medicines Patent Pool, ViiV Healthcare Sign Licence for the Most Recent HIV Medicine to Have Received Regulatory Approval

 Access to dolutegravir could improve millions of lives in developing countries The Medicines Patent Pool (MPP) and ViiV Healthcare announced a new...